Goodwin Biotechnology Inc.
AREVA Med LLC Selects Goodwin Biotechnology Inc. as a Partner for Its New Cancer Treatment
Published in Drug Law Weekly, June 2nd, 2009
Goodwin Biotechnology Inc. (GBI) disclosed today that following its recent formation, AREVA Med LLC has decided to extend its collaboration with GBI toward the development of AREVA Med’s lead-212 (212Pb) initiative to treat cancer. The operation previously engaged with AREVA will continue with AREVA Med and will result in the manufacture of a new conjugated drug that will be radiolabeled by the NCI. AREVA Med will benefit from the vast expertise in the nuclear industry from its parent company that allowed for the production of this radioisotope previously considered a scarce resource.
David Fischer, EVP of GBI, said “We are pleased to learn of the expansion of AREVA’s...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2009-06-02)
More Articles from Drug Law Weekly
- American Physical Therapy Association
Physical Therapists Advocate for Access to Rehabilitative Services on Capitol Hill - Antiretrovirals
Studies from University of Nigeria provide new data on antiretrovirals - Biosense Webster, Inc.
Benefits of Catheter Ablation with the NAVISTAR® THERMOCOOL® Catheter Sustained for One Year in the Treatment of Symptomatic, Paroxysmal Atrial Fibrillation - Biovail Corporation
Biovail Announces Termination of HSR Waiting Period, Closing of Acquisition of U.S. Rights to Wellbutrin XL® - Bureau of Alcohol, Tobacco, Firearms and Explosives
ATF Teams Up With Partners in Operation Money Train - Campaign for Tobacco-Free Kids
Sen. Judd Gregg Votes to Protect America's Kids from Tobacco - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
